πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8367697

Kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367691

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367660

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362253

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362043

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362032

Bicyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357702

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354419

Benzimidazole analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354427

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343980

Quinazoles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8344153

Inhibitors of phosphatidylinositol 3-kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8344147

Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343998

Triazolothiadiazole inhibitor of c-Met protein kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8343763

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338597

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338412

Inhibitors of P38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329702

Heterocycles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329662

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324220

Pyrimidines useful as modulators of voltage-gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324242

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324207

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318733

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318467

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314141

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted